Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuo Yoshimoto

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|April 19, 2005
Nuclear-cytoplasmic shuttling of a RING-IBR protein RBCK1 and its functional interaction with nuclear body proteinsKenji Tatematsu, Nobuo Yoshimoto, Tomoyoshi Koyanagi, et al.
International Heart Journal|August 30, 2008
Effect of angiotensin converting enzyme inhibitors and beta-blockers on left ventricular remodeling after coronary artery bypass graft surgeryYoshiaki Maruyama, Nobuyuki Masaki, Shunichi Sato, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 22, 2011
Hepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cellsMitsuo Yamada, Ayako Oeda, Joohee Jung, et al.
International Journal of Cardiology|August 4, 2010
Enhancement of ultrasonic thrombus imaging using novel liposomal bubbles targeting activated platelet glycoprotein IIb/IIIa complex--in vitro and in vivo studyKohsuke Hagisawa, Toshihiko Nishioka, Ryo Suzuki, et al.
International Journal of Nanomedicine|August 1, 2012
Engineered hepatitis B virus surface antigen L protein particles for in vivo active targeting of splenic dendritic cellsHidenori Matsuo, Nobuo Yoshimoto, Masumi Iijima, et al.
Cardiovascular Drugs and Therapy|October 26, 2013
Eicosapentaenoic Acid combined with optimal statin therapy improves endothelial dysfunction in patients with coronary artery diseaseKentaro Toyama, Toshihiko Nishioka, Ami Isshiki, et al.
Biochemical and Biophysical Research Communications|April 28, 2016
Mutational analysis of hepatitis B virus pre-S1 (9-24) fusogenic peptideQiushi Liu, Masaharu Somiya, Naohiko Shimada, et al.
Protein Expression and Purification|April 26, 2011
Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiaeJoohee Jung, Masumi Iijima, Nobuo Yoshimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 29, 2006
Association of takotsubo cardiomyopathy and long QT syndromeOsamu Sasaki, Toshihiko Nishioka, Takashi Akima, et al.
International Journal of Nanomedicine|July 24, 2015
Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapyQiushi Liu, Joohee Jung, Masaharu Somiya, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|April 19, 2005
Nuclear-cytoplasmic shuttling of a RING-IBR protein RBCK1 and its functional interaction with nuclear body proteinsKenji Tatematsu, Nobuo Yoshimoto, Tomoyoshi Koyanagi, et al.
International Heart Journal|August 30, 2008
Effect of angiotensin converting enzyme inhibitors and beta-blockers on left ventricular remodeling after coronary artery bypass graft surgeryYoshiaki Maruyama, Nobuyuki Masaki, Shunichi Sato, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 22, 2011
Hepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cellsMitsuo Yamada, Ayako Oeda, Joohee Jung, et al.
International Journal of Cardiology|August 4, 2010
Enhancement of ultrasonic thrombus imaging using novel liposomal bubbles targeting activated platelet glycoprotein IIb/IIIa complex--in vitro and in vivo studyKohsuke Hagisawa, Toshihiko Nishioka, Ryo Suzuki, et al.
International Journal of Nanomedicine|August 1, 2012
Engineered hepatitis B virus surface antigen L protein particles for in vivo active targeting of splenic dendritic cellsHidenori Matsuo, Nobuo Yoshimoto, Masumi Iijima, et al.
Cardiovascular Drugs and Therapy|October 26, 2013
Eicosapentaenoic Acid combined with optimal statin therapy improves endothelial dysfunction in patients with coronary artery diseaseKentaro Toyama, Toshihiko Nishioka, Ami Isshiki, et al.
Biochemical and Biophysical Research Communications|April 28, 2016
Mutational analysis of hepatitis B virus pre-S1 (9-24) fusogenic peptideQiushi Liu, Masaharu Somiya, Naohiko Shimada, et al.
Protein Expression and Purification|April 26, 2011
Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiaeJoohee Jung, Masumi Iijima, Nobuo Yoshimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 29, 2006
Association of takotsubo cardiomyopathy and long QT syndromeOsamu Sasaki, Toshihiko Nishioka, Takashi Akima, et al.
International Journal of Nanomedicine|July 24, 2015
Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapyQiushi Liu, Joohee Jung, Masaharu Somiya, et al.
Pageof 6